Polyclonal Rabbit anti‑Human NFIL3 Antibody (30‑110 aa, Internal, IF, WB) LS‑C383235
Polyclonal Rabbit anti‑Human NFIL3 Antibody (30‑110 aa, Internal, IF, WB) LS‑C383235
Antibody:
NFIL3 Rabbit anti-Human Polyclonal (30-110 aa, Internal) Antibody
Application:
IF, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Overview
Antibody:
NFIL3 Rabbit anti-Human Polyclonal (30-110 aa, Internal) Antibody
Application:
IF, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Specifications
Description
NFIL3 antibody LS-C383235 is an unconjugated rabbit polyclonal antibody to NFIL3 (30-110 aa, Internal) from human. It is reactive with human, mouse and rat. Validated for ELISA, IF and WB.
Target
Human NFIL3
Synonyms
NFIL3 | E4 promoter-binding protein 4 | E4BP4 | NF-IL3A | NFIL3A | IL3BP1
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human E4BP4
Epitope
30-110 aa, Internal
Specificity
E4BP4 Polyclonal Antibody detects endogenous levels of E4BP4 protein.
Applications
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- ELISA (1:20000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Monkey, Mouse, Rat, Bovine, Chicken
Applications:
ICC, Immunofluorescence, Western blot
Species:
Human, Mouse
Applications:
IHC, Immunofluorescence, Western blot
Reactivity:
Human
Range:
2.5-50 ng/ml
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/22/2024